31 Mar 2024
Assets34.65
Total Income24.37
EBITDA4.08
Profit After Tax2.14
NET Worth6.21
Reserves and Surplus2.93
Total Borrowing15.13
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue41.94₹ Cr · -8.8% vs prior year
EBITDA10.34₹ Cr · -9.4% vs prior year
PAT5.74₹ Cr · -20.6% vs prior year
Assets66.07₹ Cr · +16.9% vs prior year
Net Worth28.52₹ Cr · +25.2% vs prior year
Borrowing26.73₹ Cr · +20.6% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2025
Assets56.52
Total Income45.97
EBITDA11.41
Profit After Tax7.23
NET Worth22.78
Reserves and Surplus18.75
Total Borrowing22.16
31 Jan 2026
Assets66.07
Total Income41.94
EBITDA10.34
Profit After Tax5.74
NET Worth28.52
Reserves and Surplus24.49
Total Borrowing26.73
IPO UPDATE ALERTS
Register for IPO Updates →Track Avience Biomedicals without missing an update
Register for subscription, GMP, allotment and listing notifications.